New data showing rapid and durable full-length MECP2 expression in vivo with single-stranded AAV support improvements ...
Johnson & Johnson (NYSE: JNJ) will hold an Enterprise Business Review for the investment community on Tuesday, December 8 th, ...
Mihriban brings extensive experience in healthcare operations, quality management, analytics, and performance improvement to ...
Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, ...
The same drug product, NV-387 Oral Gummies, is also in a Phase II clinical trial for the treatment of Mpox (Monkeypox) in DRC ...
Joint system-level testing combines Stevanato Group glass syringes with Aptar Pharma elastomer components to provide key data ...
(n=6) remain disease-free more than two years after treatment 80% of patients treated with SYNC-T Therapy SV-102 (n=15) alive ...
The Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General Hospital, and ...
Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the ...
Pluri Inc. (Nasdaq and TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company advancing cell-based solutions for ...
(GLOBE NEWSWIRE)-- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged ...
BioInvent's CEO Martin Welschof will present the report together with CFO Stefan Ericsson. The presentation will be held in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results